Alzheimer's disease is the most common neurodegenerative disorder. Its pathological development is connected with the misfolding and accumulation of two toxic proteins: amyloid-β and tau proteins. Mathematical models provide a valuable quantitative tool for monitoring disease progression. In this work, we proposed and compare a novel framework where the spatio-temporal dynamics of amyloid-β and tau proteins is modeled based on employing either three-dimensional patient-specific geometries or through reduced network-based models defined on the brain connectome. More specifically, a high-fidelity biophysical model is proposed on three-dimensional brain geometries reconstructed from magnetic resonance imaging, whereas a network-based reduced formulation is defined on the brain connectome. For both approaches, a suitable numerical discretization is proposed. A sensitivity analysis is presented to quantify the influence of model parameters on protein concentration patterns as well as compare the quality of the predictions. For both approaches, the results are compared with group-level PET-SUVR clinical data using [18F]AZD4694 for amyloid-β and [18F]MK6240 for tau protein. The results indicate that the three-dimensional model provides the most accurate and biologically consistent description of the disease progression, but remains computationally demanding. On the other hand, the reduced graph-based model is cheaper, but it is not always able to achieve reliable results.
High-fidelity and network-based spatio-temporal mathematical models of Alzheimer’s disease progression and their comparison with PET-SUVR imaging data
Caon, Beatrice;Corti, Mattia;Bonizzoni, Francesca;Antonietti, Paola F.
2026-01-01
Abstract
Alzheimer's disease is the most common neurodegenerative disorder. Its pathological development is connected with the misfolding and accumulation of two toxic proteins: amyloid-β and tau proteins. Mathematical models provide a valuable quantitative tool for monitoring disease progression. In this work, we proposed and compare a novel framework where the spatio-temporal dynamics of amyloid-β and tau proteins is modeled based on employing either three-dimensional patient-specific geometries or through reduced network-based models defined on the brain connectome. More specifically, a high-fidelity biophysical model is proposed on three-dimensional brain geometries reconstructed from magnetic resonance imaging, whereas a network-based reduced formulation is defined on the brain connectome. For both approaches, a suitable numerical discretization is proposed. A sensitivity analysis is presented to quantify the influence of model parameters on protein concentration patterns as well as compare the quality of the predictions. For both approaches, the results are compared with group-level PET-SUVR clinical data using [18F]AZD4694 for amyloid-β and [18F]MK6240 for tau protein. The results indicate that the three-dimensional model provides the most accurate and biologically consistent description of the disease progression, but remains computationally demanding. On the other hand, the reduced graph-based model is cheaper, but it is not always able to achieve reliable results.| File | Dimensione | Formato | |
|---|---|---|---|
|
Caon et al. - 2026 - High-fidelity and network-based spatio-temporal mathematical models of Alzheimer’s disease progressi.pdf
Accesso riservato
:
Publisher’s version
Dimensione
4.96 MB
Formato
Adobe PDF
|
4.96 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



